TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension (CSRPH)
Brief Summary: The purpose of this study is to study the differential short-term effect of nocturnal oxygen, acetazolamide tablets and nocturnal non-invasive positive pressure ventilation on symptoms, exercise capacity and nocturnal breathing disturbances in subjects with pulmonary hypertension and sleep related breathing disorders

* Trial with medicinal product


Options:
A: Arm Label: acetazolamide; Type: EXPERIMENTAL; Interventions: Drug: acetazolamide | Arm Label: Placebo tablet; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tablet | Arm Label: supplemental oxygen during nights; Type: EXPERIMENTAL; Interventions: Other: Supplemental oxygen | Arm Label: Non-invasive ventilation; Type: EXPERIMENTAL; Interventions: Procedure: Non-invasive ventilation | Arm Label: room air; Type: SHAM_COMPARATOR; Interventions: Other: Room air | Intervention Type: DRUG; Name: acetazolamide; Assigned to Arm(s): acetazolamide | Intervention Type: OTHER; Name: Supplemental oxygen; Assigned to Arm(s): supplemental oxygen during nights | Intervention Type: PROCEDURE; Name: Non-invasive ventilation; Assigned to Arm(s): Non-invasive ventilation | Intervention Type: OTHER; Name: Room air; Assigned to Arm(s): room air | Intervention Type: DRUG; Name: Placebo tablet; Assigned to Arm(s): Placebo tablet
B: Arm Label: Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Europe: AutoSet CS (USA: VPAP Adapt SV) | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Europe: AutoSet CS (USA: VPAP Adapt SV); Assigned to Arm(s): Treatment Group
C: Arm Label: Zolpidem, then No Treatment; Type: EXPERIMENTAL; Interventions: Drug: Zolpidem, Other: No Treatment | Arm Label: No Treatment, then Zolpidem; Type: EXPERIMENTAL; Interventions: Drug: Zolpidem, Other: No Treatment | Intervention Type: DRUG; Name: Zolpidem; Assigned to Arm(s): No Treatment, then Zolpidem, Zolpidem, then No Treatment | Intervention Type: OTHER; Name: No Treatment; Assigned to Arm(s): No Treatment, then Zolpidem, Zolpidem, then No Treatment
D: Arm Label: Treatment Group; Type: EXPERIMENTAL; Interventions: Device: Treatment Group (transvenous stimulation of the phrenic nerve) | Arm Label: Control group; Type: OTHER; Interventions: Device: Control Group (Optimal Medical Therapy) | Intervention Type: DEVICE; Name: Treatment Group (transvenous stimulation of the phrenic nerve); Assigned to Arm(s): Treatment Group | Intervention Type: DEVICE; Name: Control Group (Optimal Medical Therapy); Assigned to Arm(s): Control group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Combined Remote Ischemic Preconditioning and Postconditioning on Acute Pulmonary Injury in Patients Undergoing Valvular Heart Surgery
Brief Summary: Pulmonary dysfunction after cardiac surgery with CPB remains to be a problem complicating the postoperative course of the patients. The investigators hypothesized that RIPCcom, combined intervention of remote ischemic preconditioning and remote ischemic postconditioning, would confer beneficial influence on inflammatory response and resultant postoperative pulmonary dysfunction after CPB in patients undergoing complex valvular heart surgery who are at increased risk of postoperative pulmonary dysfunction.The aim of this study was to evaluate the lung-protective effect of combined remote ischemic pre- and post-conditioning in patients undergoing complex valvular heart surgery.


Options:
A: Arm Label: HOE 140; Type: EXPERIMENTAL; Interventions: Drug: HOE 140 | Arm Label: Aminocaproic Acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aminocaproic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: HOE 140; Assigned to Arm(s): HOE 140 | Intervention Type: DRUG; Name: Aminocaproic Acid; Assigned to Arm(s): Aminocaproic Acid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Drug: Methylprednisolone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Methylprednisolone; Assigned to Arm(s): Treatment | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Atorvastatin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atorvastatin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): Atorvastatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: RIPCcom group; Type: EXPERIMENTAL; Interventions: Procedure: remote ischemic pre and postconditioning (RIPC) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: remote ischemic pre and postconditioning (RIPC); Assigned to Arm(s): RIPCcom group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Combined Remote Ischemic Preconditioning and Postconditioning on Acute Pulmonary Injury in Patients Undergoing Valvular Heart Surgery
Brief Summary: Pulmonary dysfunction after cardiac surgery with CPB remains to be a problem complicating the postoperative course of the patients. The investigators hypothesized that RIPCcom, combined intervention of remote ischemic preconditioning and remote ischemic postconditioning, would confer beneficial influence on inflammatory response and resultant postoperative pulmonary dysfunction after CPB in patients undergoing complex valvular heart surgery who are at increased risk of postoperative pulmonary dysfunction.The aim of this study was to evaluate the lung-protective effect of combined remote ischemic pre- and post-conditioning in patients undergoing complex valvular heart surgery.


Options:
A: Arm Label: Sevoflurane; Type: EXPERIMENTAL; Interventions: Procedure: Sevoflurane preconditioning | Arm Label: No Sevoflurane; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Sevoflurane preconditioning; Assigned to Arm(s): Sevoflurane
B: Arm Label: RIPCcom group; Type: EXPERIMENTAL; Interventions: Procedure: remote ischemic pre and postconditioning (RIPC) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: remote ischemic pre and postconditioning (RIPC); Assigned to Arm(s): RIPCcom group
C: Arm Label: RemotePostConditioning; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Remote Postconditioning | Arm Label: Controls; Type: SHAM_COMPARATOR; Interventions: Procedure: Remote Postconditioning | Intervention Type: PROCEDURE; Name: Remote Postconditioning; Assigned to Arm(s): Controls, RemotePostConditioning
D: Arm Label: Thrombolysis + Remote perconditioning; Type: EXPERIMENTAL; Interventions: Procedure: Thrombolysis + remote perconditioning | Arm Label: Thrombolysis; Type: ACTIVE_COMPARATOR; Interventions: Drug: Actilyse | Intervention Type: DRUG; Name: Actilyse; Assigned to Arm(s): Thrombolysis | Intervention Type: PROCEDURE; Name: Thrombolysis + remote perconditioning; Assigned to Arm(s): Thrombolysis + Remote perconditioning

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Technologically Enhanced Community Health Worker (CHW) Delivery of Personalized Diabetes Information
Brief Summary: Two of AHRQ 's consumer-focused guides, "Pills for Type 2 Diabetes" and "Premixed Insulin for Type 2 Diabetes" could be of great use to underserved ethnic and racial minority adults. The presentation of content and delivery mechanisms of these Guides, however, needs to be modified to increase their use and impact among these difficult-to-reach populations.

To achieve this goal, a long-standing collaboration among African American and Latino community organizations, health care centers and systems, public health organizations, and academics (the REACH Detroit Partnership) is joining with leading experts in the development of personally and culturally tailored health decision aids (University of Michigan's Center for Health Communications Research \[CHCR\] and Center for Behavioral and Decision Sciences in Medicine \[CBDSM\]).

The investigators will develop and evaluate a computer tailored online diabetes medication decision aid that will enable community health workers (CHWs) to provide personalized patient education materials to underserved diabetic African American and Latino adults in Detroit, Michigan.


Options:
A: Intervention Type: BEHAVIORAL; Name: Self-Help Intervention Program-High Blood Pressure; Assigned to Arm(s): N/A
B: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Diabetes Peer Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Peer Counseling | Intervention Type: BEHAVIORAL; Name: Diabetes Peer Counseling; Assigned to Arm(s): Diabetes Peer Counseling
C: Intervention Type: BEHAVIORAL; Name: Comprehensive pharmacy care program; Assigned to Arm(s): N/A
D: Arm Label: Traditional CERSG Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Community Health Worker Diabetes Education: Print media | Arm Label: Web-Based Materials Arm; Type: EXPERIMENTAL; Interventions: Behavioral: CHW Diabetes Education: tailored web site | Intervention Type: BEHAVIORAL; Name: Community Health Worker Diabetes Education: Print media; Assigned to Arm(s): Traditional CERSG Arm | Intervention Type: BEHAVIORAL; Name: CHW Diabetes Education: tailored web site; Assigned to Arm(s): Web-Based Materials Arm

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Technologically Enhanced Community Health Worker (CHW) Delivery of Personalized Diabetes Information
Brief Summary: Two of AHRQ 's consumer-focused guides, "Pills for Type 2 Diabetes" and "Premixed Insulin for Type 2 Diabetes" could be of great use to underserved ethnic and racial minority adults. The presentation of content and delivery mechanisms of these Guides, however, needs to be modified to increase their use and impact among these difficult-to-reach populations.

To achieve this goal, a long-standing collaboration among African American and Latino community organizations, health care centers and systems, public health organizations, and academics (the REACH Detroit Partnership) is joining with leading experts in the development of personally and culturally tailored health decision aids (University of Michigan's Center for Health Communications Research \[CHCR\] and Center for Behavioral and Decision Sciences in Medicine \[CBDSM\]).

The investigators will develop and evaluate a computer tailored online diabetes medication decision aid that will enable community health workers (CHWs) to provide personalized patient education materials to underserved diabetic African American and Latino adults in Detroit, Michigan.


Options:
A: Arm Label: Telemedicine; Type: EXPERIMENTAL; Interventions: Device: Telemedicine | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: DEVICE; Name: Telemedicine; Assigned to Arm(s): Telemedicine | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care
B: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: mHealth intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: mHealth intervention; Assigned to Arm(s): Intervention Group
C: Arm Label: Traditional CERSG Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Community Health Worker Diabetes Education: Print media | Arm Label: Web-Based Materials Arm; Type: EXPERIMENTAL; Interventions: Behavioral: CHW Diabetes Education: tailored web site | Intervention Type: BEHAVIORAL; Name: Community Health Worker Diabetes Education: Print media; Assigned to Arm(s): Traditional CERSG Arm | Intervention Type: BEHAVIORAL; Name: CHW Diabetes Education: tailored web site; Assigned to Arm(s): Web-Based Materials Arm
D: Intervention Type: BEHAVIORAL; Name: TRANSLATE; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Technologically Enhanced Community Health Worker (CHW) Delivery of Personalized Diabetes Information
Brief Summary: Two of AHRQ 's consumer-focused guides, "Pills for Type 2 Diabetes" and "Premixed Insulin for Type 2 Diabetes" could be of great use to underserved ethnic and racial minority adults. The presentation of content and delivery mechanisms of these Guides, however, needs to be modified to increase their use and impact among these difficult-to-reach populations.

To achieve this goal, a long-standing collaboration among African American and Latino community organizations, health care centers and systems, public health organizations, and academics (the REACH Detroit Partnership) is joining with leading experts in the development of personally and culturally tailored health decision aids (University of Michigan's Center for Health Communications Research \[CHCR\] and Center for Behavioral and Decision Sciences in Medicine \[CBDSM\]).

The investigators will develop and evaluate a computer tailored online diabetes medication decision aid that will enable community health workers (CHWs) to provide personalized patient education materials to underserved diabetic African American and Latino adults in Detroit, Michigan.


Options:
A: Arm Label: A - coded unit ID; Type: EXPERIMENTAL; Interventions: Other: clinical decision support | Arm Label: B - coded unit ID; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: clinical decision support; Assigned to Arm(s): A - coded unit ID
B: Arm Label: e-POCT; Type: EXPERIMENTAL; Interventions: Other: Management of febrile children using e-POCT | Arm Label: ALMANACH; Type: ACTIVE_COMPARATOR; Interventions: Other: Management of febrile children using ALMANACH | Arm Label: Routine practice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Management of febrile children using e-POCT; Assigned to Arm(s): e-POCT | Intervention Type: OTHER; Name: Management of febrile children using ALMANACH; Assigned to Arm(s): ALMANACH
C: Arm Label: Traditional CERSG Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Community Health Worker Diabetes Education: Print media | Arm Label: Web-Based Materials Arm; Type: EXPERIMENTAL; Interventions: Behavioral: CHW Diabetes Education: tailored web site | Intervention Type: BEHAVIORAL; Name: Community Health Worker Diabetes Education: Print media; Assigned to Arm(s): Traditional CERSG Arm | Intervention Type: BEHAVIORAL; Name: CHW Diabetes Education: tailored web site; Assigned to Arm(s): Web-Based Materials Arm
D: Arm Label: Health-E You App Participants; Type: EXPERIMENTAL; Interventions: Behavioral: Health-E You: a computer-based intervention to improve the use of effective contraception among Hispanic adolescents | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health-E You: a computer-based intervention to improve the use of effective contraception among Hispanic adolescents; Assigned to Arm(s): Health-E You App Participants

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Two Clinic-based Interventions to Promote Early Initiation and Exclusive Breastfeeding Through 6 Months After Birth in Kinshasa, Democratic Republic of Congo
Brief Summary: A cluster-randomized controlled trial will be conducted in the Democratic Republic of Congo to compare rates of early initiation and exclusive breastfeeding between mothers who give birth in hospitals with the current standard of care, mothers who give birth in hospitals that have implemented the first nine steps of the Baby-Friendly Hospital Initiative, and mothers who give birth in hospitals that have implemented all ten steps of the Baby-Friendly Hospital Initiative, with the 10th step being the provision of breastfeeding support during well-child clinic visits.


Options:
A: Arm Label: BFHI steps 1-9; Type: EXPERIMENTAL; Interventions: Other: implementation of the Baby-Friendly Hospital Initiative | Arm Label: BFHI steps 1-9 +well-child clinic; Type: EXPERIMENTAL; Interventions: Other: BFHI steps 1-9 +well-child clinic | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: implementation of the Baby-Friendly Hospital Initiative; Assigned to Arm(s): BFHI steps 1-9 | Intervention Type: OTHER; Name: BFHI steps 1-9 +well-child clinic; Assigned to Arm(s): BFHI steps 1-9 +well-child clinic
B: Intervention Type: BEHAVIORAL; Name: Improved management of severe neonatal infections; Assigned to Arm(s): N/A
C: Arm Label: Breastfeeding Clinic; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Breastfeeding Clinic | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Breastfeeding Clinic; Assigned to Arm(s): Breastfeeding Clinic
D: Arm Label: Family groups; Type: EXPERIMENTAL; Interventions: Behavioral: Family groups | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family groups; Assigned to Arm(s): Family groups

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Two Clinic-based Interventions to Promote Early Initiation and Exclusive Breastfeeding Through 6 Months After Birth in Kinshasa, Democratic Republic of Congo
Brief Summary: A cluster-randomized controlled trial will be conducted in the Democratic Republic of Congo to compare rates of early initiation and exclusive breastfeeding between mothers who give birth in hospitals with the current standard of care, mothers who give birth in hospitals that have implemented the first nine steps of the Baby-Friendly Hospital Initiative, and mothers who give birth in hospitals that have implemented all ten steps of the Baby-Friendly Hospital Initiative, with the 10th step being the provision of breastfeeding support during well-child clinic visits.


Options:
A: Arm Label: Breastfeeding Clinic; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Breastfeeding Clinic | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Breastfeeding Clinic; Assigned to Arm(s): Breastfeeding Clinic
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: LC and Electronic Prompt | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: LC and Electronic Prompt; Assigned to Arm(s): 1
C: Arm Label: BFHI steps 1-9; Type: EXPERIMENTAL; Interventions: Other: implementation of the Baby-Friendly Hospital Initiative | Arm Label: BFHI steps 1-9 +well-child clinic; Type: EXPERIMENTAL; Interventions: Other: BFHI steps 1-9 +well-child clinic | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: implementation of the Baby-Friendly Hospital Initiative; Assigned to Arm(s): BFHI steps 1-9 | Intervention Type: OTHER; Name: BFHI steps 1-9 +well-child clinic; Assigned to Arm(s): BFHI steps 1-9 +well-child clinic
D: Arm Label: Doula; Type: EXPERIMENTAL; Interventions: Behavioral: Doula | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Doula; Assigned to Arm(s): Doula

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Carbetocin at Elective Cesarean Delivery: A Dose Finding Study (Part 2)
Brief Summary: Post-partum hemorrhage (PPH) is a major cause of maternal death worldwide. Oxytocin is the most common uterotonic drug used to prevent and treat PPH in North America, however, there are some limitations to its use. Oxytocin has a very short duration of action, which requires a continuous infusion to achieve sustained uterotonic activity. The Society of Obstetricians and Gynecologists of Canada (SOGC) has recently recommended a single 100mcg dose of carbetocin at elective Cesarean delivery to promote uterine contraction and prevent post partum hemorrhage (PPH), in lieu of the more traditional oxytocin regimens. Carbetocin lasts 4 to 7 times longer than oxytocin, with a similar side effect profile and apparent greater efficacy rate. However, a dose response to determine the minimum effective dose of carbetocin has not yet been published. The investigators hypothesize that the minimum effective dose (ED90) is above 20mcgs and below 80mcgs in women undergoing elective Cesarean delivery.


Options:
A: Arm Label: Misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Oxytocin
B: Arm Label: Carbetocin 20mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 40mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 60mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 80mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Carbetocin 100mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Intervention Type: DRUG; Name: Carbetocin; Assigned to Arm(s): Carbetocin 20mcg | Intervention Type: DRUG; Name: Carbetocin; Assigned to Arm(s): Carbetocin 40mcg | Intervention Type: DRUG; Name: Carbetocin; Assigned to Arm(s): Carbetocin 60mcg | Intervention Type: DRUG; Name: Carbetocin; Assigned to Arm(s): Carbetocin 80mcg | Intervention Type: DRUG; Name: Carbetocin; Assigned to Arm(s): Carbetocin 100mcg
C: Arm Label: Carbetocin; Type: N/A; Interventions: N/A | Arm Label: Oxytocin; Type: N/A; Interventions: N/A
D: Arm Label: Saline group; Type: EXPERIMENTAL; Interventions: Drug: Oxytocin | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Saline group

Answer: B